CSET Events

The New Bio Frontier

Creating an Ecosystem for a Healthy and Secure Future

Join us on March 25 for a fireside chat with IQT’s Vice President of Technology, Dr. Jessica Dymond, to discuss the current state of emerging biotechnology, the promises it holds, and the steps that policymakers, investors, and practitioners can take to build a robust biotechnology sector.

Register Here

From CRISPR innovations fueling medical advances to biomanufacturing critical materials to AI-enabled tools unlocking new discoveries at the forefront of health science, biotechnology sits at the center for the next generation of U.S. innovation. Building robust innovation hubs and supporting the field’s foundational infrastructure will fuel U.S. global competitiveness and security. 

Join us on March 25 for a fireside chat with IQT’s Vice President of Technology, Dr. Jessica Dymond, to discuss the current state of emerging biotechnology, the promises it holds, and the steps that policymakers, investors, and practitioners can take to build a robust biotechnology sector. Register for in-person attendance at the RSVP link below. If you are unable to attend in person, you can register for virtual participation here. 

Participants

Steph Batalis is a Research Fellow at Georgetown’s Center for Security and Emerging Technology (CSET). Her research examines a number of issues at the intersection of AI and the life sciences, including how emerging technologies will impact both biomedical innovation and U.S. biosecurity. Before joining CSET, Steph was the STEM Policy Fellow at the North Carolina Biotechnology Center where she focused on economic and workforce development initiatives in North Carolina’s life sciences ecosystem. Steph earned her Ph.D. in Biochemistry and Molecular Biology with a focus in Structural and Computational Biophysics from Wake Forest University’s School of Medicine and a B.A. in Molecular and Cellular Biology from Vanderbilt University.

Dr. Jessica Dymond is the Vice President, Technology and technical lead of IQT’s biotechnology practice, B.Next. She provides technical and strategic leadership across Engineering Biology and Human Health and Performance, developing and executing a strategic investment strategy to address critical national security challenges and future transformative capabilities. At IQT, she focuses on investments within the Chemical/Biological Defense and Engineering Biology domains, leveraging her background in biosecurity and emerging tech analysis. Prior to joining IQT, Dr. Dymond was the Chief Scientist at the Johns Hopkins University Applied Physics Laboratory (APL). There, she led research to enhance anticipation, assessment, and mitigation of emerging biological threats, and integrated health surveillance strategies. She also served as Assistant Program Area Manager for Health Protection and Assurance and founded the Biological Sciences research group.